$1.50
-0.08-5.06%
At close: -
$1.55
0.053.33%
After Hours: Jan 17, 7:58 PM EDT
Hoth Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Hoth Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.31 | $-0.32 | 3.12 % |
Q2 | 2024-08-09 | $-0.24 | $-0.47 | 48.9 % |
Q1 | 2024-05-14 | $-0.46 | $-0.43 | -6.98 % |
Q4 | 2024-03-28 | $-0.31 | $-0.51 | 39.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Hoth Therapeutics (HOTH) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.31, which beat the estimate of $-0.32.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.